CD8A and triple-negative breast carcinoma: Tokumaru et al. demonstrated that the enrichment of KRAS signaling is associated with improved survival and favorable TIMEs enriched with B cells, CD8 T cells, M1 macrophages and monocytes in triple negative breast cancer (Tokumaru et al., 2020).